{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:14:59Z","timestamp":1789582499495,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s1043661802001743","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T13:39:14Z","timestamp":1034170754000},"page":"301-310","source":"Crossref","is-referenced-by-count":3,"title":["CARDIOTOXIC INTERACTION OF METABOLITES FROM A PRODRUG SEGMENT CILEXETIL (CYCLOHEXYLOXY-CARBONYLOXY-ETHYL) WITH DIGOXIN IN THE CANINE FAILING HEART"],"prefix":"10.1016","volume":"46","author":[{"given":"HIDEKI","family":"OKUNISHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEIKO","family":"SHIMOURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANG-QIAO","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EIICHI","family":"KAKIZOE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1043661802001743_BIB1","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0149-2918(01)80086-2","article-title":"Tenecteplase: a review","volume":"23","author":"Davydov","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/S1043661802001743_BIB2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/1389200013338504","article-title":"The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions","volume":"2","author":"Bachmann","year":"2001","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/S1043661802001743_BIB3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/bdd.236","article-title":"Dose staggering as a strategy to reduce drug\u2013drug interactions due to reversible enzyme inhibition between orally administered drugs with high first pass effect: a computer simulation study","volume":"21","author":"Fang","year":"2000","journal-title":"Biopharm. Drug Dispos."},{"issue":"Suppl. 6","key":"10.1016\/S1043661802001743_BIB4","first-page":"146","article-title":"Metabolic fate of cefotiam hexetil, a new oral cephalosporin antibiotic, in rats, mice, and dogs [abstract in English]","volume":"36","author":"Tanayama","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1016\/S1043661802001743_BIB5","first-page":"980","article-title":"Efficacy and safety of cefotiam hexetil in the treatment of ear, nose and throat infections","volume":"42","author":"Maier","year":"1992","journal-title":"Arzneimittelforschung"},{"issue":"Suppl. 6","key":"10.1016\/S1043661802001743_BIB6","first-page":"126","article-title":"Gas chromatographic determination of metabolites of the ester side-chain of cefotiam hexetil (2HCl) in human plasma and urine [abstract in English]","volume":"36","author":"Okada","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl. 6","key":"10.1016\/S1043661802001743_BIB7","first-page":"167","article-title":"General pharmacological studies on cefotiam hexetil (2HCl) [abstract in English]","volume":"36","author":"Kito","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl. 6","key":"10.1016\/S1043661802001743_BIB8","first-page":"146","article-title":"Metabolic fate of cefotiam, a new oral cephalosporin antibiotic, in rats, mice, and dogs [abstract in English]","volume":"36","author":"Tanayama","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl. 6","key":"10.1016\/S1043661802001743_BIB9","first-page":"180","article-title":"Phase I clinical study on cefotiam hexetil [abstract in English]","volume":"36","author":"Tateno","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1016\/S1043661802001743_BIB10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jat\/15.1.13","article-title":"Determination of cyclohexanol in urine and its use in environmental monitoring of cyclohexanone exposure","volume":"15","author":"Ong","year":"1991","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/S1043661802001743_BIB11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/clinchem\/36.6.870","article-title":"Urinary excretion of cyclohexanediol, a metabolite of the solvent cyclohexanone, by infants in a special care unit","volume":"36","author":"Millis","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/S1043661802001743_BIB12","unstructured":"Jackson EK. Renin and angiotensin. In: Hardman JG, Limbird LE, Gilman AG, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill, 2001: 809\u201341."},{"key":"10.1016\/S1043661802001743_BIB13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0895-7061(00)01304-2","article-title":"Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators","volume":"14","author":"Weir","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/S1043661802001743_BIB14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/01.RES.69.4.1058","article-title":"Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy","volume":"69","author":"Spinale","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/S1043661802001743_BIB15","first-page":"235","article-title":"Characteristics and clinical relevance of animal models of heart failure","volume":"10","author":"Elsner","year":"1995","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/S1043661802001743_BIB16","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.CIR.100.10.1032","article-title":"Role of angiotensin receptor blockers in heart failure not yet RESOLVD","volume":"100","author":"Greenberg","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S1043661802001743_BIB17","doi-asserted-by":"crossref","unstructured":"The RESOLVD Investigators. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the Randomized Evaluation of Strategies for Left Ventricular Dysfunction Pilot Study. Circulation 2000; 101: 378\u201384.","DOI":"10.1161\/01.CIR.101.4.378"},{"issue":"Heart Circ. Physiol. 34","key":"10.1016\/S1043661802001743_BIB18","first-page":"H1119","article-title":"Exhaustion of Frank\u2013Starling mechanism in conscious dogs with heart failure","volume":"265","author":"Komamura","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S1043661802001743_BIB19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-3659(01)00233-4","article-title":"Model prodrugs for the intestinal oligopeptide transporter: model drug release in aqueous solution and in various biological media","volume":"73","author":"Nielsen","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/S1043661802001743_BIB20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7164\/antibiotics.50.429","article-title":"Synthesis and structure\u2013activity relationships of a novel oral carbapenem, CS-834","volume":"50","author":"Miyauchi","year":"1997","journal-title":"J. Antibiot."},{"key":"10.1016\/S1043661802001743_BIB21","unstructured":"Ooi H, Colucci WS. Pharmacological treatment of heart failure. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman\u2019s the pharmacological basis of therapeutics. 10th edn. New York: McGraw-Hill, 2001: 901\u201332."},{"key":"10.1016\/S1043661802001743_BIB22","unstructured":"Akera T, Brown BS. Cardiovascular toxicology of cardiotonic drugs and chemicals. In: Stee EWVS, ed. Cardiovascular toxicology. 1st edn. New York: Raven Press, 1982: 109\u201334."},{"key":"10.1016\/S1043661802001743_BIB23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.83.1","article-title":"Drug-induced torsade de pointes: from molecular biology to bedside","volume":"83","author":"Tamargo","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/S1043661802001743_BIB24","unstructured":"Roden DM. Antiarrhythmic drugs. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman\u2019s the pharmacological basis of therapeutics. 10th edn. New York: McGrwa-Hill, 2001: 933\u201370."},{"issue":"Suppl. 1","key":"10.1016\/S1043661802001743_BIB25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00002018-199921001-00003","article-title":"Blockade of cardiac potassium and other channels by antihistamines","volume":"21","author":"Delp\u00f3n","year":"1999","journal-title":"Drug Saf."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661802001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661802001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T14:09:26Z","timestamp":1583676566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661802001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S1043661802001743"],"URL":"https:\/\/doi.org\/10.1016\/s1043661802001743","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}